@FierceMedDev: After another quarterly slide, Wright Medical is planning to reorganize. Report | Follow @FierceMedDev
@MarkHFierce: FDA warns the maker of a light therapy product designed to treat fungal meningitis that the product is unapproved. More | Follow @MarkHFierce
@DamianFierce: Myriad Genetics is raising its full-year guidance after a strong quarter. More | Follow @DamianFierce
> China's Mindray Medical ($MR) has shuffled its top ranks as co-CEO Xu Hang has resigned, leaving Li Xiting the sole head of the company. News
> Looking to finance its upcoming mitosis, Abbott Laboratories' ($ABT) AbbVie spinoff raised $14.7 billion in the largest dollar-denominated debt issue ever. After the January split, devices and diagnostics will remain under the Abbott moniker, while drug development will fall to the newfangled AbbVie. Story
> The global market for urology devices is poised to explode, according to analysts, predicted to reach $8.6 billion by 2022. Article
> Becton Dickinson ($BDX) has named William Kozy as its new chief operating officer, a position he will fill in addition to his current job as executive vice president. More
> American Medical Systems is recalling some of its AdVance slings in Europe, warning that the sutures they contain may not last as long as labeled. Item
> Medtronic ($MDT) has donated $250,000 to the Red Cross to support victims of Hurricane Sandy. Release
Biotech News
@FierceBiotech: From FierceVaccines.com: PsiOxus lands $2.7M for ovarian cancer vaccine trial. Item | Follow @FierceBiotech
@JohnCFierce: Buyout Buzz: The most frequently cited takeover targets in biotech. Special Report | Follow @JohnCFierce
@RyanMFierce: Crowdsourcing kick spurs interest in NIH drug recycling. More | Follow @RyanMFierce
> PCSK9 rivals Amgen and Pfizer angle for AHA spotlight with promising data. Story
> Takeda snaps up CNS drug developer Envoy Therapeutics in $140M deal. News
> Ambit Biosciences finds $50M more from VCs as leukemia therapy advances. Article
Pharma News
@FiercePharma: Congressional hearings on the meningitis debacle to begin next week. FDA's Hamburg on the sked: Report | Follow @FiercePharma
> Teva shunts Americas chief aside in management shuffle. Article
> Bristol-Myers to slash 480 sales-related jobs in NJ. Story
Biotech Research News
> Failed AstraZeneca drugs gain second chance with $11M U.K. program. News
> UC Davis team finds new lung cancer Rx target. Article
> 'Abdominal imaging window' lets researchers crack cancer metastasis secrets. Story
> Scientists wield stem cells to undo male infertility inflicted by cancer treatment in monkeys. More
Pharma Manufacturing News
> Sigma-Aldrich gets foothold in S. Korea with API deal. Article
> German Bayer partners with Russian drug manufacturer. News
> India's price-setting agency prepares for plant inspections. Story